Someone please correct me on this -
but it also looks like they claim to have developed two compounds
which are more potent selective inhibitors of BRD4 than apabetalone ?
ZLO240 and ZLO454
Of course they are not in clinical trials yet,
and Don claims that RVX has several follow-on compounds more potent than RVX-208
waiting in the wings, but .....
thoughts anyone?